CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Por um escritor misterioso
Last updated 11 abril 2025
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Proteomic landscape of SARS-CoV-2– and MERS-CoV–infected primary human renal epithelial cells
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
IJMS, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Human Cell Receptors and Downstream Cascades: A Review of Molecular Aspects and Potential Therapeutic Targets in COVID-19, Archives of Pediatric Infectious Diseases
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Cells, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Cells, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

© 2014-2025 likytut.eu. All rights reserved.